Are streptokinase antibodies clinically important?
Open Access
- 1 August 1993
- Vol. 70 (2), 101-102
- https://doi.org/10.1136/hrt.70.2.101
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Streptokinase resistance: when might streptokinase administration be ineffective?Heart, 1992
- Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgGHeart, 1992
- Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarctionAmerican Heart Journal, 1992
- Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.Heart, 1991
- Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.Heart, 1990
- Antistreptokinase titres after intravenous streptokinaseThe Lancet, 1990
- Thrombolytic Therapy with Streptokinase Using a Standard Dosage SchemeBMJ, 1966